Head circumference as an early predictor of fetal death in fetuses with increased nuchal translucency: evidence from a multicenter cohort study

头围作为颈项透明层增厚胎儿死亡的早期预测指标:一项多中心队列研究的证据

阅读:1

Abstract

OBJECTIVES: To assess the value of early gestational head circumference (HC) for predicting subsequent fetal death in women whose fetuses had increased nuchal translucency (NT). METHODS: Gestational age-specific NT and HC Z scores were calculated. The threshold for NT was confirmed by comparing the difference in HC predictive value for fetal death (including early fetal death [12-19 weeks] and stillbirth [≥ 20 weeks]) between NT groups (normal or increased NT). Thresholds for HC prediction of fetal death in fetuses with increased NT were confirmed, with corresponding sensitivity and specificity. The performance and clinical value of the model were evaluated. Multiple imputation method was conducted to assess the robustness of the results. RESULTS: A total of 16,436 women and their fetuses were included in the analysis. Fetal HC was lower in fetal deaths than in live births (P < 0.005). The 80th percentile was a preferred threshold for increased NT. The difference in HC between live and dead fetuses persisted in fetuses with NT > 80th percentile (median of HC Z score: - 0.66 vs. 0.34, P < 0.001), but not in those with NT ≤ 80th percentile. The HC Z score was valuable for predicting fetal death in fetuses with increased NT, with a sensitivity of 74% and specificity of 76%. The prediction was useful for early fetal death, not stillbirth. Internal validation showed that the model has good predictive performance and clinical utility. Multiply imputation analysis shows that the association of low HC with fetal death and its predictive value were weakened. CONCLUSIONS: The early gestational age-specific HC Z score was associated with fetal death, particularly early fetal death, in fetuses with NT above the 80th percentile. Definitive validation through large-scale cohorts with protocol-based routine HC measurements is warranted before considering clinical application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。